CVS Health Corporation (NYSE:CVS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of CVS Health Corporation (NYSE:CVS) have been assigned an average recommendation of “Moderate Buy” from the twenty-seven research firms that are currently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation, twenty-one have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $89.4091.

CVS has been the topic of several recent research reports. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Wolfe Research increased their price target on shares of CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Monday, September 22nd. Leerink Partners boosted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Mizuho increased their target price on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Finally, Jefferies Financial Group boosted their price target on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th.

CVS Health Price Performance

CVS stock opened at $76.52 on Friday. The firm has a 50 day simple moving average of $78.03 and a two-hundred day simple moving average of $70.14. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62. The stock has a market cap of $97.13 billion, a PE ratio of 201.36, a P/E/G ratio of 0.87 and a beta of 0.60. CVS Health has a one year low of $43.56 and a one year high of $85.15.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period in the previous year, the business earned $1.09 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts predict that CVS Health will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Institutional Trading of CVS Health

A number of institutional investors have recently made changes to their positions in CVS. Avion Wealth boosted its position in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the period. Harbor Capital Advisors Inc. raised its stake in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Corundum Trust Company INC purchased a new position in CVS Health during the 3rd quarter valued at about $29,000. Finally, Harbor Asset Planning Inc. purchased a new position in CVS Health during the 2nd quarter valued at about $30,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.